Evidence map›Paper›PMID 37584292›Full record

ArticleHaematologica2024

Red cell distribution width as a new prognostic biomarker in refractory chronic graft-

Eduard Schulz, Filip Pirsl, Noa G Holtzman, David Beshensky, Edward W Cowen, Sandra A Mitchell, Seth M Steinberg, Steven Z Pavletic

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eduard SchulzCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892.
Filip PirslCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Noa G HoltzmanCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892.
David BeshenskyCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Edward W CowenDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892.
Sandra A MitchellOutcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, 20850.
Seth M SteinbergBiostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Steven Z PavleticCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892. pavletis@mail.nih.gov.

Funding

Office of Collaborative BiostatisticsZIDSC007202 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI CHOO-WOSOBA, HYOYOUNG · 2009 to 2025
$14.5M
NIH Chronic GVHD Study GroupZIABC011743 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PAVLETIC, STEVEN · 2016 to 2025
$10.2M
Chronic graft-versus-host diseaseZIAAR041227 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COWEN, EDWARD · 2022 to 2025
$1.4M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bronchiolitis Obliterans SyndromeGraft vs Host DiseaseBiomarkersChronic DiseaseErythrocyte IndicesHumansPrognosisBiomarkers

Identifiers

PMID37584292
PMCPMC10772496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.